Mark S. Warren

3.2k total citations · 1 hit paper
34 papers, 2.4k citations indexed

About

Mark S. Warren is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Mark S. Warren has authored 34 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Materials Chemistry and 10 papers in Oncology. Recurrent topics in Mark S. Warren's work include Enzyme Structure and Function (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Biochemical and Molecular Research (8 papers). Mark S. Warren is often cited by papers focused on Enzyme Structure and Function (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Biochemical and Molecular Research (8 papers). Mark S. Warren collaborates with scholars based in United States and Japan. Mark S. Warren's co-authors include Olga Lomovskaya, Kazuki Hoshino, Hiroko Ishida, Suzanne Chamberland, Elizabeth E. Howell, Ving J. Lee, Anita R. Mistry, Stephen J. Benkovic, Angela Lee and Jorge L. Galazzo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Molecular Biology.

In The Last Decade

Mark S. Warren

34 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy

2001 731 citations Olga Lomovskaya, Mark S. Warren et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Warren United States	23	1.3k	1.0k	447	353	301	34	2.4k
Focco van den Akker United States	33	1.6k 1.2×	962 0.9×	606 1.4×	208 0.6×	205 0.7×	80	3.3k
Glenn E. Dale Switzerland	35	1.6k 1.2×	489 0.5×	462 1.0×	403 1.1×	240 0.8×	63	3.0k
Joaquim Trias United States	27	1.2k 0.9×	675 0.6×	371 0.8×	493 1.4×	405 1.3×	44	2.4k
Emilia Caselli Italy	25	1.1k 0.8×	869 0.8×	478 1.1×	159 0.5×	130 0.4×	52	2.2k
Markus A. Seeger Switzerland	33	1.9k 1.4×	1.1k 1.0×	309 0.7×	1.1k 3.1×	630 2.1×	71	3.7k
David E. Ehmann United States	22	994 0.7×	1.1k 1.1×	1.0k 2.3×	159 0.5×	131 0.4×	29	2.2k
Daniel Lim United States	23	3.0k 2.2×	323 0.3×	192 0.4×	429 1.2×	467 1.6×	38	4.4k
Sherin S. Abdel‐Meguid United States	27	1.2k 0.9×	279 0.3×	191 0.4×	302 0.9×	129 0.4×	52	2.5k
Steven L. Roderick United States	31	2.6k 2.0×	308 0.3×	208 0.5×	604 1.7×	385 1.3×	53	3.5k
Hiroshi Hiasa United States	31	2.6k 1.9×	696 0.7×	581 1.3×	473 1.3×	484 1.6×	72	3.4k

Countries citing papers authored by Mark S. Warren

Since Specialization

Citations

This map shows the geographic impact of Mark S. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Warren more than expected).

Fields of papers citing papers by Mark S. Warren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Warren. The network helps show where Mark S. Warren may publish in the future.

Co-authorship network of co-authors of Mark S. Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Warren. A scholar is included among the top collaborators of Mark S. Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Warren. Mark S. Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Warren, Mark S., et al.. (2025). Identification of selective substrates and inhibitors of the major human renal uptake transporters. Drug Metabolism and Disposition. 53(3). 100046–100046. 1 indexed citations

Shemesh, Colby S., Rosie Z. Yu, Mark S. Warren, et al.. (2017). Assessment of the Drug Interaction Potential of Unconjugated and GalNAc3-Conjugated 2′-MOE-ASOs. Molecular Therapy — Nucleic Acids. 9. 34–47. 27 indexed citations

Yu, Rosie Z., Mark S. Warren, Tanya Watanabe, et al.. (2016). Lack of Interactions Between an Antisense Oligonucleotide with 2′- O -(2-Methoxyethyl) Modifications and Major Drug Transporters. Nucleic Acid Therapeutics. 26(2). 111–117. 22 indexed citations

Zhang, Yan, Mark S. Warren, Xuexiang Zhang, et al.. (2015). Impact on Creatinine Renal Clearance by the Interplay of Multiple Renal Transporters: A Case Study with INCB039110. Drug Metabolism and Disposition. 43(4). 485–489. 33 indexed citations

Gil-Henn, Hava, Antonia Patsialou, Yidong Wang, et al.. (2012). Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. Oncogene. 32(21). 2622–2630. 105 indexed citations

Warren, Mark S., Noa Zerangue, Lori M. Roberts, et al.. (2009). Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacological Research. 59(6). 404–413. 191 indexed citations

Mao, Weimin, Mark S. Warren, Deborah S. Black, et al.. (2002). On the mechanism of substrate specificity by resistance nodulation division (RND)‐type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Molecular Microbiology. 46(3). 889–901. 101 indexed citations

Lomovskaya, Olga, et al.. (2001). Characterization of pacidamycin resistant mutants in Pseudomonas aeruginosa. 101. 8. 2 indexed citations

Galazzo, Jorge L., Andrew L. Staley, Julie C. Lee, et al.. (2001). Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Il Farmaco. 56(1-2). 81–85. 82 indexed citations

10.

Lomovskaya, Olga, Mark S. Warren, Angela Lee, et al.. (2001). Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy. Antimicrobial Agents and Chemotherapy. 45(1). 105–116. 731 indexed citations breakdown →

11.

Boger, Dale L., Mark S. Warren, Joseph Ramcharan, et al.. (1997). Abenzyl 10-formyl-trideazafolic acid (abenzyl 10-formyl-TDAF): An effective inhibitor of glycinamide ribonucleotide transformylase. Bioorganic & Medicinal Chemistry. 5(9). 1847–1852. 12 indexed citations

12.

Boger, Dale L., et al.. (1997). Functionalized analogues of 5,8,10-trideazafolate as potential inhibitors of GAR Tfase or AICAR Tfase. Bioorganic & Medicinal Chemistry. 5(9). 1831–1838. 18 indexed citations

13.

Warren, Mark S. & Stephen J. Benkovic. (1997). Combinatorial manipulation of three key active site residues in glycinamide ribonucleotide transformylase. Protein Engineering Design and Selection. 10(1). 63–68. 36 indexed citations

14.

Boger, Dale L., et al.. (1997). Multisubstrate analogue based on 5,8,10-trideazafolate. Bioorganic & Medicinal Chemistry. 5(9). 1853–1857. 12 indexed citations

15.

Klein, Claudio, Ping Chen, Jairo H. Arevalo, et al.. (1995). Towards Structure-based Drug Design: Crystal Structure of a Multisubstrate Adduct Complex of Glycinamide Ribonucleotide Transformylase at 1.96 Å Resolution. Journal of Molecular Biology. 249(1). 153–175. 65 indexed citations

16.

Warren, Mark S., et al.. (1991). Investigation of the functional role of tryptophan-22 in Escherichia coli dihydrofolate reductase by site-directed mutagenesis. Biochemistry. 30(46). 11092–11103. 30 indexed citations

17.

Howell, Elizabeth E., et al.. (1990). A second-site mutation at phenylalanine-137 that increases catalytic efficiency in the mutant aspartate-27 .fwdarw. serine Escherichia coli dihydrofolate reductase. Biochemistry. 29(37). 8561–8569. 27 indexed citations

18.

Howell, Elizabeth E., Mark S. Warren, Carol L. J. Booth, J. Ernest Villafranca, & J. Kraut. (1987). Construction of an altered proton donation mechanism in Escherichia coli dihydrofolate reductase. Biochemistry. 26(26). 8591–8598. 37 indexed citations

19.

Kraut, J., J. Ernest Villafranca, Elizabeth E. Howell, Stuart J. Oatley, & Mark S. Warren. (1986). A structure—function study of dihydrofolate reductase by protein engineering. Philosophical Transactions of the Royal Society of London Series A Mathematical and Physical Sciences. 317(1540). 405–413. 6 indexed citations

20.

Howell, Elizabeth E., J. Ernest Villafranca, Mark S. Warren, Stuart J. Oatley, & Joseph Kraut. (1986). Functional Role of Aspartic Acid-27 in Dihydrofolate Reductase Revealed by Mutagenesis. Science. 231(4742). 1123–1128. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact